Spotlight Series
Stay updated with insights from Adial’s executives on the latest company news and key developments in addiction research.
When Policy Finally Catches Up to the Science on Alcohol Addiction
03/05/2026
Inside Congress’s recent directive to the FDA on AUD and the Administration’s push for modern, patient-centered alcohol treatments.
read more →
Damp January: Rethinking How Progress Is Defined in Alcohol Use Disorder
01/28/2026
Moving beyond all-or-nothing: defining progress through fewer risks, not perfection.
read more →
Uncorking the truth: Why women’s alcohol use is rising and what we’re missing in treatment
11/19/2025
A conversation with Dr. Robertson on the trend of rising rates of alcoholism among women.
read more →
Alcohol Use Disorder: A Growing Public Health and Economic Threat
08/12/2025
Alcohol Use Disorder (AUD) is not only widespread; it’s intensifying. With nearly half a million Americans dying from alcohol-related causes every year and 400 million individuals affected globally, the burden is staggering.
read more →
Less Can Be More: Rethinking What Alcohol Recovery Looks Like
07/07/2025
What if recovery from alcohol use disorder didn’t have to mean quitting cold turkey?
read more →
Strategic Growth & Innovation: Tony Goodman on Adial’s Vision for Precision Medicine
04/03/2025
Adial’s approach with AD04 integrates a genetic focus, specifically targeting certain genotypes. How has this personalized medicine approach been received within the addiction treatment community?
read more →
From Data to Recovery: Transforming AUD Treatment with Precision Medicine
01/29/2025
Adial Pharmaceuticals is leveraging genetic insights to redefine AUD care with targeted, patient-specific solutions Since its inception, Adial Pharmaceuticals has recognized the potential of precision medicine in treating Alcohol Use Disorder (AUD). Built on a commitment to scientific innovation, Adial has dedicated itself to developing therapeutic interventions that take into…
read more →